Current trends in preoperative biliary stenting in patients with pancreatic cancer

Lindsay J. Jinkins, Abhishek D. Parmar, Yimei Han, Casey B. Duncan, Kristin M. Sheffield, Kimberly M. Brown, Taylor S. Riall

Research output: Contribution to journalArticle

37 Citations (Scopus)

Abstract

Background: Sufficient evidence suggests that preoperative biliary stenting is associated with increased complication rates after pancreaticoduodenectomy. Methods: Surveillance, Epidemiology, and End Results (SEER) and linked Medicare claims data (1992-2007) were used to identify patients with pancreatic cancer who underwent pancreaticoduodenectomy. We evaluated trends in the use of preoperative biliary stenting, timing of physician visits relative to stenting, and time to surgical resection and symptoms in stented and unstented patients. Results: Pancreaticoduodenectomy was performed in 2,573 patients, and 52.6% of patients underwent preoperative biliary stenting (N = 1,354). Of these, 75.3% underwent endoscopic stenting only, 18.9% received a percutaneous stent, and 5.8% underwent both procedures. The overall stenting rate increased from 29.6% of patients between 1992 and 1995 to 59.1% between 2004 and 2007 (P <.0001). Preoperative stenting was more common in patients with jaundice, cholangitis, pruritus, or coagulopathy (P <.05 for all). Of stented patients, 77.7% had had a stent placed prior to seeing a surgeon. Stenting prior to surgical consultation was associated with longer indwelling stent time compared to stenting after surgical consultation (37.3 vs 27.0 days, P <.0001). In addition, stented patients had longer times from surgeon visit to pancreatectomy than those who had not received stents (24.2 days vs 17.2 days, P <.0001). Conclusion: Use of preoperative biliary stenting doubled between 1992 and 2007 despite evidence that stenting is associated with increased perioperative infectious complications. The majority of stenting occurred prior to surgical consultation and is associated with significant delay in time to operation. Surgeons should be involved early in order to prevent unnecessary stenting and improve outcomes.

Original languageEnglish (US)
Pages (from-to)179-189
Number of pages11
JournalSurgery (United States)
Volume154
Issue number2
DOIs
StatePublished - Aug 2013

Fingerprint

Pancreatic Neoplasms
Pancreaticoduodenectomy
Stents
Referral and Consultation
Pancreatectomy
Cholangitis
Pruritus
Medicare
Jaundice
Epidemiology
Physicians
Surgeons

ASJC Scopus subject areas

  • Surgery

Cite this

Jinkins, L. J., Parmar, A. D., Han, Y., Duncan, C. B., Sheffield, K. M., Brown, K. M., & Riall, T. S. (2013). Current trends in preoperative biliary stenting in patients with pancreatic cancer. Surgery (United States), 154(2), 179-189. https://doi.org/10.1016/j.surg.2013.03.016

Current trends in preoperative biliary stenting in patients with pancreatic cancer. / Jinkins, Lindsay J.; Parmar, Abhishek D.; Han, Yimei; Duncan, Casey B.; Sheffield, Kristin M.; Brown, Kimberly M.; Riall, Taylor S.

In: Surgery (United States), Vol. 154, No. 2, 08.2013, p. 179-189.

Research output: Contribution to journalArticle

Jinkins, LJ, Parmar, AD, Han, Y, Duncan, CB, Sheffield, KM, Brown, KM & Riall, TS 2013, 'Current trends in preoperative biliary stenting in patients with pancreatic cancer', Surgery (United States), vol. 154, no. 2, pp. 179-189. https://doi.org/10.1016/j.surg.2013.03.016
Jinkins LJ, Parmar AD, Han Y, Duncan CB, Sheffield KM, Brown KM et al. Current trends in preoperative biliary stenting in patients with pancreatic cancer. Surgery (United States). 2013 Aug;154(2):179-189. https://doi.org/10.1016/j.surg.2013.03.016
Jinkins, Lindsay J. ; Parmar, Abhishek D. ; Han, Yimei ; Duncan, Casey B. ; Sheffield, Kristin M. ; Brown, Kimberly M. ; Riall, Taylor S. / Current trends in preoperative biliary stenting in patients with pancreatic cancer. In: Surgery (United States). 2013 ; Vol. 154, No. 2. pp. 179-189.
@article{cf4660100c24429ab55f6f045001536d,
title = "Current trends in preoperative biliary stenting in patients with pancreatic cancer",
abstract = "Background: Sufficient evidence suggests that preoperative biliary stenting is associated with increased complication rates after pancreaticoduodenectomy. Methods: Surveillance, Epidemiology, and End Results (SEER) and linked Medicare claims data (1992-2007) were used to identify patients with pancreatic cancer who underwent pancreaticoduodenectomy. We evaluated trends in the use of preoperative biliary stenting, timing of physician visits relative to stenting, and time to surgical resection and symptoms in stented and unstented patients. Results: Pancreaticoduodenectomy was performed in 2,573 patients, and 52.6{\%} of patients underwent preoperative biliary stenting (N = 1,354). Of these, 75.3{\%} underwent endoscopic stenting only, 18.9{\%} received a percutaneous stent, and 5.8{\%} underwent both procedures. The overall stenting rate increased from 29.6{\%} of patients between 1992 and 1995 to 59.1{\%} between 2004 and 2007 (P <.0001). Preoperative stenting was more common in patients with jaundice, cholangitis, pruritus, or coagulopathy (P <.05 for all). Of stented patients, 77.7{\%} had had a stent placed prior to seeing a surgeon. Stenting prior to surgical consultation was associated with longer indwelling stent time compared to stenting after surgical consultation (37.3 vs 27.0 days, P <.0001). In addition, stented patients had longer times from surgeon visit to pancreatectomy than those who had not received stents (24.2 days vs 17.2 days, P <.0001). Conclusion: Use of preoperative biliary stenting doubled between 1992 and 2007 despite evidence that stenting is associated with increased perioperative infectious complications. The majority of stenting occurred prior to surgical consultation and is associated with significant delay in time to operation. Surgeons should be involved early in order to prevent unnecessary stenting and improve outcomes.",
author = "Jinkins, {Lindsay J.} and Parmar, {Abhishek D.} and Yimei Han and Duncan, {Casey B.} and Sheffield, {Kristin M.} and Brown, {Kimberly M.} and Riall, {Taylor S.}",
year = "2013",
month = "8",
doi = "10.1016/j.surg.2013.03.016",
language = "English (US)",
volume = "154",
pages = "179--189",
journal = "Surgery",
issn = "0039-6060",
publisher = "Mosby Inc.",
number = "2",

}

TY - JOUR

T1 - Current trends in preoperative biliary stenting in patients with pancreatic cancer

AU - Jinkins, Lindsay J.

AU - Parmar, Abhishek D.

AU - Han, Yimei

AU - Duncan, Casey B.

AU - Sheffield, Kristin M.

AU - Brown, Kimberly M.

AU - Riall, Taylor S.

PY - 2013/8

Y1 - 2013/8

N2 - Background: Sufficient evidence suggests that preoperative biliary stenting is associated with increased complication rates after pancreaticoduodenectomy. Methods: Surveillance, Epidemiology, and End Results (SEER) and linked Medicare claims data (1992-2007) were used to identify patients with pancreatic cancer who underwent pancreaticoduodenectomy. We evaluated trends in the use of preoperative biliary stenting, timing of physician visits relative to stenting, and time to surgical resection and symptoms in stented and unstented patients. Results: Pancreaticoduodenectomy was performed in 2,573 patients, and 52.6% of patients underwent preoperative biliary stenting (N = 1,354). Of these, 75.3% underwent endoscopic stenting only, 18.9% received a percutaneous stent, and 5.8% underwent both procedures. The overall stenting rate increased from 29.6% of patients between 1992 and 1995 to 59.1% between 2004 and 2007 (P <.0001). Preoperative stenting was more common in patients with jaundice, cholangitis, pruritus, or coagulopathy (P <.05 for all). Of stented patients, 77.7% had had a stent placed prior to seeing a surgeon. Stenting prior to surgical consultation was associated with longer indwelling stent time compared to stenting after surgical consultation (37.3 vs 27.0 days, P <.0001). In addition, stented patients had longer times from surgeon visit to pancreatectomy than those who had not received stents (24.2 days vs 17.2 days, P <.0001). Conclusion: Use of preoperative biliary stenting doubled between 1992 and 2007 despite evidence that stenting is associated with increased perioperative infectious complications. The majority of stenting occurred prior to surgical consultation and is associated with significant delay in time to operation. Surgeons should be involved early in order to prevent unnecessary stenting and improve outcomes.

AB - Background: Sufficient evidence suggests that preoperative biliary stenting is associated with increased complication rates after pancreaticoduodenectomy. Methods: Surveillance, Epidemiology, and End Results (SEER) and linked Medicare claims data (1992-2007) were used to identify patients with pancreatic cancer who underwent pancreaticoduodenectomy. We evaluated trends in the use of preoperative biliary stenting, timing of physician visits relative to stenting, and time to surgical resection and symptoms in stented and unstented patients. Results: Pancreaticoduodenectomy was performed in 2,573 patients, and 52.6% of patients underwent preoperative biliary stenting (N = 1,354). Of these, 75.3% underwent endoscopic stenting only, 18.9% received a percutaneous stent, and 5.8% underwent both procedures. The overall stenting rate increased from 29.6% of patients between 1992 and 1995 to 59.1% between 2004 and 2007 (P <.0001). Preoperative stenting was more common in patients with jaundice, cholangitis, pruritus, or coagulopathy (P <.05 for all). Of stented patients, 77.7% had had a stent placed prior to seeing a surgeon. Stenting prior to surgical consultation was associated with longer indwelling stent time compared to stenting after surgical consultation (37.3 vs 27.0 days, P <.0001). In addition, stented patients had longer times from surgeon visit to pancreatectomy than those who had not received stents (24.2 days vs 17.2 days, P <.0001). Conclusion: Use of preoperative biliary stenting doubled between 1992 and 2007 despite evidence that stenting is associated with increased perioperative infectious complications. The majority of stenting occurred prior to surgical consultation and is associated with significant delay in time to operation. Surgeons should be involved early in order to prevent unnecessary stenting and improve outcomes.

UR - http://www.scopus.com/inward/record.url?scp=84880856770&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84880856770&partnerID=8YFLogxK

U2 - 10.1016/j.surg.2013.03.016

DO - 10.1016/j.surg.2013.03.016

M3 - Article

C2 - 23889947

AN - SCOPUS:84880856770

VL - 154

SP - 179

EP - 189

JO - Surgery

JF - Surgery

SN - 0039-6060

IS - 2

ER -